Top Trending Tickers On StockTwits For March 13

Here's a look at the top tickers trending on StockTwits.com.

Plug Power: Anticipated earnings impress investors

This morning, Plug Power PLUG reported its highly anticipated fourth quarter results. The company announced an EPS of -$0.08 in-line with the consensus estimate. Revenue of $8 million beat the consensus estimate of $7.45 million.

Unadjusted net loss grew to $28.9 million from $8.47 million in the same quarter last year partially due to a charge related to a change in the fair value of a previous common stock warrant issue.

See also: Five Star Stock Watch - EMC Corp.

Plug Power is predicting that its orders will rise more than four times this year to more than $150 million and the company is expecting to be EBITDA break even by the third quarter.

Gogo: Earnings beat

This morning, Gogo GOGO reported its fourth quarter results. The company announced an EPS of -$0.26, beating the consensus estimate of -$0.27. Revenue of $92.6 million beat the consensus estimate of $85.68 million. Service revenue rose 44 percent year over year to $69.7 million while equipment revenue rose 52 percent to $22.9 million in the same time period.

Net loss for the quarter improved to $22.1 million from a net loss of $36.0 million in the same quarter last year as operating expenses rose to $107.0 million in the quarter from $73.1 million last year.

Gogo issued guidance and sees its full year 2014 revenue to be $400 million to $422 million, versus a consensus estimate of $414.23 million.

Amazon: Prime users to fork over an extra $2o

Amazon.com AMZN announced that the price of its Prime service will be raised to $99 a year. The change will be effective in seven days and existing members will see the new price when their membership is set to renew. Many StockTwits members are posting that they have received e-mail notifications relating to the price increase.

Amazon hinted that it will increase its Prime membership following a disappointing earnings report in January. Loyal Prime users could breathe a sigh of relief as the price hike to $99 is less than $119 price management previously hinted at.

Idera Pharmaceuticals: Investors finding plenty of reasons to be positive

This morning, Idera Pharmaceuticals IDRA reported its fourth quarter results. The company announced an EPS of -$0.10, missing the consensus estimate of -$0.08. Revenue of $4,000 missed the consensus estimate of $10,000.

Net loss for the quarter fell to $6,369 from $6,528 in the same quarter last year.

Idera announced that it plans to begin clinical development of its lead compound, IMO-8400 which could be used for the treatment of patients with polymyositis and patients with dermatomyositis. The company will submit a protocol to the U.S. Food and Drug Administration in the first half of 2014 for a Phase 1/2 clinical trial.

Activision: Analyst boost

Analysts at Bank of America upgraded Activision Blizzard ATVI to Buy from Neutral with a price target raised to $25 from a previous $20.

The analysts noted, “we see several upcoming title catalysts including a Diablo 3 expansion (3/25), Destiny (9/9), a WoW expansion (2H14), Hearthstone (out of Beta this quarter), and an online version of Call of Duty in China (possibly 2H14). Given this title slate, we see greater relative revenue and earnings upside potential than for EA. We think Destiny could be ‘the' title of E3 and a top game for next-gen console players this year. Also, a WoW expansion pack should aid sub trends. Based on strong early next-gen console sales and title line up, we are increasing our PO to $25 (from $20) based on 18x our higher 2015E EPS of $1.38 (up from $1.31), a P/E multiple in-line with Electronic Arts.”

Market News and Data brought to you by Benzinga APIs
Posted In: NewsActivission BlizzardAmazon PrimeCall of DutyDestinyDiablo 3Electronics ArtGogoIdera PharmaceuticalsIMO-8400Plug Power
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...